Prevention and treatment of cardiovascular disease in HIV: practical insights in an evolving field [0.03%]
HIV合并心血管疾病的预防和治疗：发展领域中的实用见解
Harris Avgousti,Matthew J Feinstein
Harris Avgousti
People with HIV (PWH) are at higher risk for cardiovascular disease (CVD) than people without HIV. As antiretroviral therapy (ART) and the natural history of HIV have evolved, so have the pathogenesis and manifestations of HIV-associated CV...
Albert M Anderson,Beau M Ances,Scott L Letendre
Albert M Anderson
The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) featured new and impactful findings about neuropsychiatric complications in people with HIV and other infections. Reports included new evidence of (a) the importance of...
CROI 2023: Tuberculosis and Infectious Complications in Persons With HIV [0.03%]
2023年CROI会议：HIV患者的结核病和感染并发症
Andrew D Kerkhoff,Diane V Havlir
Andrew D Kerkhoff
Novel implementation strategies to increase uptake and adherence to tuberculosis (TB) preventive therapy hold promise for reducing TB incidence in persons with HIV in high-burden settings. In persons who develop drug-susceptible TB, progres...
Sudipa Sarkar,Todd T Brown
Sudipa Sarkar
Comorbid conditions have major impacts on the health, quality of life, and survival of people with HIV, particularly as they age. The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) featured excellent science related to ...
Mario Stevenson
Mario Stevenson
The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) represented the first fully in-person conference since the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic began. CROI continues as the premier co...
Jason Zucker
Jason Zucker
The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) emphasized emerging infectious diseases such as COVID-19 and mpox. Despite emerging from countries in which it was endemic only 9 months before the conference, mpox was...
Annukka A R Antar,Michael J Peluso
Annukka A R Antar
Studies of acute and post-acute COVID-19 were presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI). Early treatment with ensitrelvir, a novel protease inhibitor, hastened viral clearance and symptom resolutio...
CROI 2023: Epidemiologic Trends and Prevention for HIV and Other Sexually Transmitted Infections [0.03%]
2023年CROI会议：艾滋病及其他性传播感染的流行趋势和预防措施
Albert Y Liu,Susan P Buchbinder
Albert Y Liu
At the 2023 Conference on Retroviruses and Opportunistic Infections (CROI), several investigators used tests of recent HIV infection to track which populations are currently most heavily impacted by HIV and to estimate HIV infection rates i...
CROI 2023: Advances in Antiviral Therapy in HIV and Viral Hepatitis [0.03%]
2023年逆转录病毒和机会性感染大会(CROI)关于HIV和病毒性肝炎的抗病毒治疗进展
Shauna H Gunaratne,Barbara S Taylor,Timothy J Wilkin et al.
Shauna H Gunaratne et al.
Several innovative methods were presented at the 2023 Conference on Retroviruses and Opportunistic Infections (CROI) targeting different aspects of the HIV care continuum to improve testing, linkage to care, and viral suppression. Some of t...
Clinical Trial
Topics in antiviral medicine. 2023 May;31(3):445-467. DOI: 2023
Robert T Schooley
Robert T Schooley
The golden age of antibiotics, which lasted from the 1930s until 2005, brought a brisk clip of antibiotic discovery and fueled optimism about the victory of modern medicine over bacterial infections. Since then, however, with a stalled anti...